(Q84049968)

English

Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer

scientific article published on 13 April 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Neoadjuvant sequential epirubicin and docetaxel followed by surgery-radiotherapy and post-operative docetaxel or gemcitabine/vinorelbine combination based on primary response: a multimodality approach for locally advanced breast cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

based on heuristic

inferred from title

author name string

Panteleimon Kountourakis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Ioannis Missitzis

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Dimitrios Doufexis

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Vassileios Zobolas

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Georgios Pissakas

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Niki Arnogiannaki

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Savoula Maliou

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Anastasia Sotiropoulou

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Alexandros Ardavanis

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

13 April 2010

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Journal of Cancer Research and Clinical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

137

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

221-228

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

https://scigraph.springernature.com/pub.10.1007/s00432-010-0878-8

0 references

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Doxorubicin with cyclophosphamide followed by docetaxel every 21 days compared with doxorubicin and docetaxel every 14 days as preoperative treatment in operable breast cancer: the GEPARDUO study of the German Breast Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sequential preoperative or postoperative docetaxel added to preoperative doxorubicin plus cyclophosphamide for operable breast cancer:National Surgical Adjuvant Breast and Bowel Project Protocol B-27

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factors.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant chemotherapy shows similar response in patients with inflammatory or locally advanced breast cancer when compared with operable breast cancer: a secondary analysis of the GeparTrio trial data

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravenous vinorelbine as first-line and second-line therapy in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of preoperative chemotherapy on the outcome of women with operable breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Multidisciplinary Therapy of Locally Far-Advanced or Inflammatory Breast Cancer with Fixed Perioperative Sequence of Epirubicin, Vinorelbine, and Fluorouracil Chemotherapy, Surgery, and Radiotherapy: Long-Term Results

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine monotherapy as salvage chemotherapy in heavily pretreated metastatic breast cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Update on locally advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine and vinorelbine as second-line treatment in patients with metastatic breast cancer: a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gemcitabine and oral vinorelbine as salvage treatment in patients with advanced anthracycline- and taxane-pretreated breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammatory breast cancer: a review

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Revision of the American Joint Committee on Cancer staging system for breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20387073

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00432-010-0878-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20387073%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84049968&oldid=1577722510"